2025年下半年中国医药人才市场趋势与动态报告

2025 H2 Beyond gauging the surge in demand for certain roles and thestabilization of others, the realm of executive positions warrants acloser look, especially given their inherent volatility. The turnoverrate among top executives has been notably on the rise, a trend that High turnover rate at theexecutivelevelin commercial sector •In 2024,6 out of the 12 leadingMNCPharmacoreplacedtheirPresidents/GMsin China.100%of those China Presidents/GMswere filled internally–2were internally promoted from local positions,while10were internally transferred from regional andglobal teams. •Duringthe second half of 2024andthe first half of 2025，atotalof 22 BUVPs out ofapproximately 50 changedtheirjobs,indicating a significant reshuffling at thisposition. This high 50% turnover rate suggests that companies are actively reevaluatingand reorganizing their business units to better align with strategic turnover at commercialexecutive level among 12 leading What keeps R&D executives lessactive in the job market? Significantlylow turnoverrate of 9% forR&D executivesamongthe 12 leadingMNC 39 R&D functional-head level leaders were interviewed byRobert Walters. What’sdriving the Recruitment Boomat MNCPharmacoin China for 2025? 2025 H1 position recruitment demand increased 2025 H1 position recruitmentdemand increased +59% Search & Evaluation MNCPharmacoare continuing to increase their investment in Chinaby establishing innovationcenters, incubators, and engaging inbusiness development (BD) collaborations with Chinese innovative drug companies. As a result,Search & Evaluation roles have grownsignificantly year-over-year, driven primarily by newly created On the side of innovative drug companies, there is still a cleardemand for out-licensing BD, with the number of positions remainingrelatively stable year-over-year. Based on successful cases in 2024, newco and financial advisor (FA) have become the preferred methods for innovative drug companies. Therefore, in terms of job 2025 H1 position recruitment +22% NPPandStrategy Additionally, the focus on key therapeutic areas where demand fornew treatments is high, underscores the importance of strategicleadership in product planning. Overall, these roles are crucial for 2025 H1 position recruitmentdemand increased +20% Medical Affairs There's a noticeable uptick in the demand for Medical Affairs roles.This surge is propelled by the expansion and dynamic shifts, whichbrim with opportunities for both growth and innovation. The Chinese government's progressive policies, including streamlined drugapproval protocols and bolstered intellectual property safeguards,have rendered China an enticing hub for R&D. Amidst the fiercecompetition in the pharmaceutical arena, where both domestic andinternational players are scrambling for market dominance, there's a heightened push for innovation and the development of novelproducts. This climate necessitates the expertise of seasoned MedicalAffairs professionals to spearhead theseendeavors. The spotlight oncritical therapeutic domains where the quest for groundbreaking 2025 H1 position recruitmentdemand increased +15% RSM/RSD/NSD Multiple MNCPharmacoexpandtheir salesbecause of new productlines. There'sbeenanincrease inhiring for specializedRespiratory, In thefirst half of 2025, we've seen higher turnover amongRSM/RSD/NSD, compared to the second halfoflast year.The major •Organizational Restructuring: Companies are optimizing their organizational •ExecutiveTurnovers: Shifts in senior management have created newopportunities and altered the working environment, prompting changes inrecruitment needs. •Career Advancement: There has been an increase in voluntary job changesas professionals seek new opportunities for career growth and 2025 H2talentmarketoutlook New Trend The logic of “independent”and“controllable" innovation in thepharmaceutical industry has gained prominence, especially against thebackdrop of the US-China trade war. This trend has led to an increaseddemand for preclinical R&D talents. As companies pursue new modalities, Demand Feature Top MNCsare increasingly adopting a "both-and" mindset, seekingcandidates who can excel in multiple areas. This trend is particularly evident inmultinational corporations undergoing transformation.Theyare no longer As a result, there is a noticeable increase in the demand for candidates withdiverse backgrounds. Companies are looking for individuals who can bring arange of skills andcapabilitiesto the table, reflecting the evolving nature of What’sourtakeon therecruitmentchallengeslooming? Onlyabout 20% of active candidates being able to secure 90% of the Marketdynamicsamidrestructuring Despite layoffs and organizational changes, there will still be demandpersistsinthe market. However, the market has shifted to a buyer's market, whereemployers have the upper hand and can set high standards for candidates.Candidates must evaluate their strengths and address skill gaps